Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alder Biopharma (ALDR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 725,032
  • Shares Outstanding, K 67,760
  • Annual Sales, $ 110 K
  • Annual Income, $ -156,250 K
  • 36-Month Beta 2.48
  • Price/Sales 6,806.90
  • Price/Cash Flow N/A
  • Price/Book 2.29

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.05 +6.97%
on 11/28/17
11.45 -6.11%
on 12/04/17
+0.45 (+4.37%)
since 11/15/17
3-Month
9.55 +12.57%
on 11/14/17
13.25 -18.87%
on 10/05/17
+0.55 (+5.39%)
since 09/15/17
52-Week
8.60 +25.00%
on 08/21/17
25.45 -57.76%
on 02/10/17
-11.05 (-50.69%)
since 12/15/16

Most Recent Stories

More News
Report: Developing Opportunities within Ionis Pharmaceuticals, Alder BioPharmaceuticals, Robert Half International, Ashford Hospitality Trust, Southwest Gas, and Stoneridge -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ionis Pharmaceuticals, Inc....

RHI : 55.26 (+1.92%)
SWX : 80.11 (+0.89%)
ALDR : 10.75 (+0.47%)
IONS : 52.39 (+1.61%)
SRI : 23.73 (+4.45%)
AHT : 6.78 (+0.44%)
Alder BioPharmaceuticals(R) to Present at 29th Annual Piper Jaffray Healthcare Conference

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that it will webcast its presentation at the 29th Annual...

ALDR : 10.75 (+0.47%)
Alder BioPharmaceuticals(R) Announces Third Quarter 2017 Financial and Operating Results

- PROMISE 2 pivotal trial completed enrollment and top-line data on track for 1H18 -

ALDR : 10.75 (+0.47%)
Alder BioPharmaceuticals(R) to Present at 26th Annual Credit Suisse Healthcare Conference

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that it will webcast its presentation at the 26th Annual...

ALDR : 10.75 (+0.47%)
Alder BioPharmaceuticals(R) to Host Conference Call to Discuss Third Quarter 2017 Financial and Operating Results

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that it will report its third quarter 2017 financial...

ALDR : 10.75 (+0.47%)
Alder BioPharmaceuticals(R) to Present Data from Eptinezumab Development Program at 18th Congress of the International Headache Society

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that eptinezumab, the company's investigational product...

ALDR : 10.75 (+0.47%)
Alder BioPharmaceuticals(R) to Present at the Morgan Stanley 15th Annual Global Healthcare Conference

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics today announced that it will webcast its presentation at the upcoming...

MS : 53.10 (+0.87%)
ALDR : 10.75 (+0.47%)
Downtrend Call Working As Alder Biopharmac Stock Falls 33.9% (ALDR)

SmarTrend identified a Downtrend for Alder Biopharmac (NASDAQ:ALDR) on June 27th, 2017 at $14.67. In approximately 2 months, Alder Biopharmac has returned 33.90% as of today's recent price of $9.70.

ALDR : 10.75 (+0.47%)
Downtrend Call Working As Alder Biopharmac Stock Falls 35.3% (ALDR)

SmarTrend identified a Downtrend for Alder Biopharmac (NASDAQ:ALDR) on June 27th, 2017 at $14.67. In approximately 2 months, Alder Biopharmac has returned 35.26% as of today's recent price of $9.50.

ALDR : 10.75 (+0.47%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Versartis Inc (VSAR, BPMC, ARRY, ALDR, FLXN)

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

VSAR : 1.95 (unch)
ARRY : 10.92 (-1.80%)
ALDR : 10.75 (+0.47%)
BPMC : 75.13 (-0.27%)
FLXN : 25.22 (+3.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and...

See More

Key Turning Points

2nd Resistance Point 11.45
1st Resistance Point 11.07
Last Price 10.75
1st Support Level 10.45
2nd Support Level 10.20

See More

52-Week High 25.45
Fibonacci 61.8% 19.01
Fibonacci 50% 17.03
Fibonacci 38.2% 15.04
Last Price 10.75
52-Week Low 8.60

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.